INSUBCONTINENT EXCLUSIVE:
Apple revealed the Apple Watch 4 at its event earlier this week, and aside from the obvious screen upgrade, the new smartwatch added
additional health features, including the ability to take an FDA-approved electrocardiogram (ECG)
serious condition known as atrial fibrillation (AFib) over 98% of the time.The Apple Watch 4 uses its wrist sensor to monitor the wearers
If it detects such activity, it alerts the wearer.The Apple-sponsored study submitted to the FDA, called the Apple Heart Study and created
in partnership with Stanford Medicine, started last November and finished earlier this month
study-specific app were able to identify over 98%of patients who had AFib and over 99% who were healthy
replacement for proper medical procedure, as Quartz points out
detection and the dangers of misinterpretation or over-reliance on the software.The FDA will consider the Apple Watch 4 a 'class II' risk
device; For reference, pacemakers are 'class III'.
